BFTHX
Price
$58.26
Change
-$0.82 (-1.39%)
Updated
Jun 13 closing price
Net Assets
707.27M
RGEBX
Price
$74.89
Change
-$0.91 (-1.20%)
Updated
Jun 13 closing price
Net Assets
306.22B
Interact to see
Advertisement

BFTHX vs RGEBX

Header iconBFTHX vs RGEBX Comparison
Open Charts BFTHX vs RGEBXBanner chart's image
Baron Fifth Avenue Growth Retail
Price$58.26
Change-$0.82 (-1.39%)
VolumeN/A
Net Assets707.27M
American Funds Growth Fund of Amer R2E
Price$74.89
Change-$0.91 (-1.20%)
VolumeN/A
Net Assets306.22B
BFTHX vs RGEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BFTHX vs. RGEBX commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BFTHX is a Buy and RGEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 306B vs. BFTHX (707M). BFTHX (0.00) and RGEBX (0.00) have matching dividends . BFTHX was incepted earlier than RGEBX: BFTHX (21 years) vs RGEBX (11 years). RGEBX (1.09) is less costly to investors than BFTHX (1.03). RGEBX is a more actively managed with annual turnover of: 25.00 vs. BFTHX (13.38). RGEBX has a lower initial minimum investment than BFTHX: RGEBX (250) vs BFTHX (2000). BFTHX annual gain was more profitable for investors over the last year : 21.50 vs. RGEBX (7.68). BFTHX (46.53) and RGEBX (45.42) have equivalent 5 years return.
BFTHXRGEBXBFTHX / RGEBX
Total Expense Ratio1.001.0992%
Annual Report Gross Expense Ratio1.031.0994%
Fund Existence21 years11 years-
Gain YTD1.8714.82939%
Front LoadN/AN/A-
Min. Initial Investment2000250800%
Min. Initial Investment IRAN/AN/A-
Net Assets707M306B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year21.507.68280%
Returns for 3 years104.5651.01205%
Returns for 5 years46.5345.42102%
Returns for 10 years205.9965.87313%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APGE44.482.62
+6.26%
Apogee Therapeutics
VVOS2.140.01
+0.47%
Vivos Therapeutics
SJM95.72-1.65
-1.69%
JM Smucker Company (The)
ELVA3.38-0.17
-4.79%
Electrovaya
NNDM1.44-0.12
-7.69%
Nano Dimension Ltd